Content Restricted
This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.
Purchase Standard Account
On January 5, 2021, the Alabama Medicaid Agency released a draft section 1115 demonstration waiver for public comment on its plan to use Medicaid funds for short-term psychiatric treatment for adults with serious mental illness (SMI) or serious emotional disturbance (SED) provided by an Institution for Mental Disease (IMD). Normally, the federal Medicaid program prohibits reimbursement for adult (ages 21 to 64) inpatient or residential psychiatric treatment provided in an IMD, which is defined as any inpatient or residential facility with more than 16 beds and a primary purpose of serving people with behavioral health disorders. The state intends . . .
